KAPILCO

Skybiotech Healthcare Share Price

 

 

Start SIP in KAPILCO

Start SIP
Skybiotech Healthcare live price: ₹153.85.

Skybiotech Healthcare Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹152.97
  • 100 DMA₹164.02
  • 200 DMA₹174.08

Investment Returns

  • Over 1 Month + 26.52%
  • Over 3 Month -12.14%
  • Over 6 Month -27.84%
  • Over 1 Year -5.96%

Smart Investing Starts Here Start SIP with Skybiotech Healthcare for Steady Growth!

Invest Now

Skybiotech Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Skybiotech Healthcare Financials

Skybiotech Healthcare Technicals

EMA & SMA

Current Price
₹153.85
-8.05 (-4.97%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹149.05
  • 50 Day
  • ₹152.97
  • 100 Day
  • ₹164.02
  • 200 Day
  • ₹174.08

Resistance and Support

153.85 Pivot Speed
  • R3 153.85
  • R2 153.85
  • R1 153.85
  • S1 153.85
  • S2 153.85
  • S3 153.85

Skybiotech Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-28 Increase in Authorised Capital
2025-08-14 Quarterly Results
2025-05-30 Audited Results

Skybiotech Healthcare F&O

Skybiotech Healthcare Shareholding Pattern

No data available.

Skybiotech Healthcare FAQs

Skybiotech Healthcare share price is ₹153 As on 31 March, 2026 | 03:50

The Market Cap of Skybiotech Healthcare is ₹29.5 Cr As on 31 March, 2026 | 03:50

The P/E ratio of Skybiotech Healthcare is -15.5 As on 31 March, 2026 | 03:50

The PB ratio of Skybiotech Healthcare is 3.6 As on 31 March, 2026 | 03:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23